160 related articles for article (PubMed ID: 25300461)
1. Plasmatic oxidative stress biomarkers in multiple sclerosis: relation with clinical and demographic characteristics.
Pasquali L; Pecori C; Lucchesi C; LoGerfo A; Iudice A; Siciliano G; Bonuccelli U
Clin Biochem; 2015 Jan; 48(1-2):19-23. PubMed ID: 25300461
[TBL] [Abstract][Full Text] [Related]
2. Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal Ig synthesis in Multiple Sclerosis patients.
Pasquali L; Pecori C; Chico L; Iudice A; Siciliano G; Bonuccelli U
J Neuroimmunol; 2015 Jun; 283():39-42. PubMed ID: 26004154
[TBL] [Abstract][Full Text] [Related]
3. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache.
Lucchesi C; Baldacci F; Cafalli M; Chico L; Lo Gerfo A; Bonuccelli U; Siciliano G; Gori S
Headache; 2015; 55(7):984-91. PubMed ID: 26129705
[TBL] [Abstract][Full Text] [Related]
4. Peripheral oxidative stress in relapsing-remitting multiple sclerosis.
Tasset I; Agüera E; Sánchez-López F; Feijóo M; Giraldo AI; Cruz AH; Gascón F; Túnez I
Clin Biochem; 2012 Apr; 45(6):440-4. PubMed ID: 22330938
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
Wang P; Xie K; Wang C; Bi J
Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
[TBL] [Abstract][Full Text] [Related]
6. Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes.
Alatab S; Maghbooli Z; Hossein-Nezhad A; Khosrofar M; Mokhtari F
Minerva Med; 2011 Dec; 102(6):461-8. PubMed ID: 22193377
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipid peroxidation and progression of disability in multiple sclerosis.
Koch M; Mostert J; Arutjunyan AV; Stepanov M; Teelken A; Heersema D; De Keyser J
Eur J Neurol; 2007 May; 14(5):529-33. PubMed ID: 17437612
[TBL] [Abstract][Full Text] [Related]
8. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study.
Abo-Krysha N; Rashed L
Mult Scler; 2008 Jun; 14(5):602-8. PubMed ID: 18408021
[TBL] [Abstract][Full Text] [Related]
9. Alteration of prolyl oligopeptidase and activated α-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.
Tenorio-Laranga J; Peltonen I; Keskitalo S; Duran-Torres G; Natarajan R; Männistö PT; Nurmi A; Vartiainen N; Airas L; Elovaara I; García-Horsman JA
Biochem Pharmacol; 2013 Jun; 85(12):1783-94. PubMed ID: 23643808
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
Kivisäkk P; Healy BC; Francois K; Gandhi R; Gholipour T; Egorova S; Sevdalinova V; Quintana F; Chitnis T; Weiner HL; Khoury SJ
Mult Scler; 2014 Apr; 20(4):438-44. PubMed ID: 24005026
[TBL] [Abstract][Full Text] [Related]
11. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress.
Oliveira SR; Simão AN; Kallaur AP; de Almeida ER; Morimoto HK; Lopes J; Dichi I; Kaimen-Maciel DR; Reiche EM
Nutrition; 2014 Mar; 30(3):268-73. PubMed ID: 24484677
[TBL] [Abstract][Full Text] [Related]
12. Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Sternberg Z; Sternberg D; Drake A; Chichelli T; Yu J; Hojnacki D
J Neuroimmunol; 2014 Sep; 274(1-2):197-201. PubMed ID: 25064498
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage.
Morel A; Bijak M; Miller E; Rywaniak J; Miller S; Saluk J
Oxid Med Cell Longev; 2015; 2015():240918. PubMed ID: 26064417
[TBL] [Abstract][Full Text] [Related]
14. Oxidative modification of serum proteins in multiple sclerosis.
Sadowska-Bartosz I; Adamczyk-Sowa M; Galiniak S; Mucha S; Pierzchala K; Bartosz G
Neurochem Int; 2013 Nov; 63(5):507-16. PubMed ID: 24036284
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis.
Niederwieser G; Buchinger W; Bonelli RM; Berghold A; Reisecker F; Költringer P; Archelos JJ
J Neurol; 2003 Jun; 250(6):672-5. PubMed ID: 12796827
[TBL] [Abstract][Full Text] [Related]
16. Assessing tissue damage in multiple sclerosis: a biomarker approach.
Burman J; Zetterberg H; Fransson M; Loskog AS; Raininko R; Fagius J
Acta Neurol Scand; 2014 Aug; 130(2):81-9. PubMed ID: 24571714
[TBL] [Abstract][Full Text] [Related]
17. Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.
Kallaur AP; Reiche EMV; Oliveira SR; Simão ANC; Pereira WLCJ; Alfieri DF; Flauzino T; Proença CM; Lozovoy MAB; Kaimen-Maciel DR; Maes M
Mol Neurobiol; 2017 Jan; 54(1):31-44. PubMed ID: 26732588
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study.
Preziosa P; Rocca MA; Mesaros S; Pagani E; Stosic-Opincal T; Kacar K; Absinta M; Caputo D; Drulovic J; Comi G; Filippi M
Radiology; 2011 Aug; 260(2):541-50. PubMed ID: 21673227
[TBL] [Abstract][Full Text] [Related]
19. Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis.
Dogonowski AM; Siebner HR; Soelberg Sørensen P; Paulson OB; Dyrby TB; Blinkenberg M; Madsen KH
Acta Neurol Scand; 2013 Nov; 128(5):328-35. PubMed ID: 23461607
[TBL] [Abstract][Full Text] [Related]
20. Regional cervical cord atrophy and disability in multiple sclerosis: a voxel-based analysis.
Valsasina P; Rocca MA; Horsfield MA; Absinta M; Messina R; Caputo D; Comi G; Filippi M
Radiology; 2013 Mar; 266(3):853-61. PubMed ID: 23192778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
